Kidney function and drug processing: a closer look
NCT ID NCT05292495
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study looked at how the drug HR17031 is processed in people with different levels of kidney function, from mild to severe kidney disease and even end-stage disease. It included 24 adults aged 18 to 70. The goal was to measure drug levels in the blood, not to treat diabetes. This information helps doctors understand how to dose the drug safely for patients with kidney issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMPROVED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 100009, China
Conditions
Explore the condition pages connected to this study.